About Bioventrix
Bioventrix is a company based in San Ramon (United States) founded in 2003 by Lon Annest. Bioventrix has raised $188.1 million across 27 funding rounds from investors including Andera Partners, Cormorant and Taglich Brothers. Bioventrix has completed 1 acquisition, including MateraCor. Bioventrix offers products and services including Heart Failure Treatment. Bioventrix operates in a competitive market with competitors including CVRx, Sequana Medical, Adona Medical, Element Science and V-Wave, among others.
- Headquarter San Ramon, United States
- Founders Lon Annest
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bioventrix, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$188.1 M (USD)
in 27 rounds
-
Latest Funding Round
Not available
-
Investors
Andera Partners
& 5 more
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bioventrix
Bioventrix offers a comprehensive portfolio of products and services, including Heart Failure Treatment.
Provides innovative options for managing heart failure in patients.
People of Bioventrix
Unlock access to complete
Unlock access to complete
Funding Insights of Bioventrix
Bioventrix has successfully raised a total of $188.1M across 27 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Bioventrix
Bioventrix has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Andera Partners, Cormorant and Taglich Brothers.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Capital is provided to firms for growth, buyouts, and acquisitions.
|
Locked | Locked | Locked | |
|
Venture capital firm focused on life science, medical device and healthcare companies
|
Locked | Locked | Locked | |
|
Manages diversified investment portfolios across various asset classes.
|
Locked | Locked | Locked |
Investor details for Bioventrix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bioventrix
Bioventrix has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include MateraCor.
Investment portfolio details for Bioventrix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of tissue regenerative therapies for treating heart diseases
|
Locked | Locked | 2018 | Locked |
Complete acquisition details for Bioventrix
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Bioventrix
Detailed financials for Bioventrix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioventrix Comparisons
Peer comparison for Bioventrix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bioventrix
Bioventrix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CVRx, Sequana Medical, Adona Medical, Element Science and V-Wave, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Implantable technology for hypertension and heart failure is developed.
|
|
| Locked | Locked | Locked |
Implantable battery-powered pumps for ascites removal are developed.
|
|
| Locked | Locked | Locked |
Medical devices for heart failure management are developed.
|
|
| Locked | Locked | Locked |
Wearable patch defibrillators are developed for sudden cardiac arrest treatment.
|
|
| Locked | Locked | Locked |
Implantable inter-atrial shunts are developed to treat chronic heart failure.
|
|
| Locked | Locked | Locked |
Minimally invasive ventriculoplasty system for heart failure and FMR
|
Detailed competitors of Bioventrix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioventrix
Complete news archive for Bioventrix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bioventrix
Bioventrix was founded in 2003 and raised its 1st funding round 1 year after it was founded.
Bioventrix is headquartered in San Ramon, United States. It is registered at San Ramon, California, United States.
David R is the current CEO of Bioventrix.
Bioventrix is a funded company, having raised a total of $188.1M across 27 funding rounds to date.
BioVentrix was founded in 2003 in San Ramon, United States, within the medical device sector focused on cardiovascular health. Clinical solutions for heart failure patients are developed, including the PliCath HF, an epicardial catheter-based device for ventricular reshaping. Operations center on research and development, with the product not yet commercially available. Expertise is contributed by co-founders such as Lon Annest and co-CEO David R.
Bioventrix's top competitors include Sequana Medical, CVRx and Adona Medical.
Bioventrix offers Heart Failure Treatment.
Bioventrix has made 1 acquisition, including MateraCor.
Bioventrix has 6 investors. Key investors include Andera Partners, Cormorant, Taglich Brothers, Squarepoint Capital, and Richmond Brothers.